Ginkgo Bioworks Holdings, Inc.
NYSE · Healthcare · Biological Products, (No Diagnostic Substances) · Boston, MA
DNA chart
What traders are saying about $DNA
Latest postsGinkgo Bioworks Holdings, Inc. news
- Did Ginkgo Bioworks Fall Catch You Out? What Investors Missed
Simply Wall Street ·
- Ginkgo Bioworks Holdings, Inc. (DNA) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- What Ginkgo Bioworks Bears Saw Before The Fall
Yahoo Finance ·
- Ginkgo Bioworks Holdings, Inc. Estimates – NYSE:DNA
TradingView ·
- Form 144 Ginkgo Bioworks Holdings For: 23 October By Investing.com
Investing.com Nigeria ·
- Form 4 Ginkgo Bioworks Holdings: Reshma P. Shetty (Director, 10% Owner, Officer) For: 16 October
Investing.com South Africa ·
- Ginkgo Bioworks CEO Jason Kelly sells $463,352 in shares
Investing.com ·
- Ginkgo Bioworks president and founder Shetty sells $417,607 in shares
Investing.com ·
- Ginkgo Bioworks CFO Steven Coen sells $7,769 of company stock
Investing.com ·
- Ginkgo Bioworks director Barry Canton sells $417,607 in stock
Investing.com ·
- Ginkgo Bioworks (DNA) 10K Form and Latest SEC Filings 2026
MarketBeat ·
- Ginkgo Bioworks CEO Jason Kelly sells $463,352 in shares By Investing.com
Investing.com South Africa ·
Ginkgo Bioworks Holdings, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $170.2M | $227.0M | $251.5M | $477.7M |
| Net income | -$313,000 | -$547,000 | -$893,000 | -$2.1M |
| Diluted EPS | $-5.64 | $-10.54 | $-18.37 | $-50.20 |
| Total assets (year end) | $1.12B | $1.38B | $1.67B | $2.54B |
| Cash and equivalents (year end) | $167.2M | $561.6M | $944.1M | $1.32B |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Ginkgo Bioworks Holdings, Inc.
- Ticker
- DNA (NYSE)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Boston, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1830214
- Former names
- Soaring Eagle Acquisition Corp., Spinning Eagle Acquisition Corp.
Frequently asked questions
What exchange is Ginkgo Bioworks Holdings, Inc. listed on?
Ginkgo Bioworks Holdings, Inc. trades on the NYSE under the ticker symbol DNA.
What industry is Ginkgo Bioworks Holdings, Inc. in?
Ginkgo Bioworks Holdings, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Ginkgo Bioworks Holdings, Inc. headquartered?
Ginkgo Bioworks Holdings, Inc.'s business address on file with the SEC is in Boston, MA.
When does Ginkgo Bioworks Holdings, Inc.'s fiscal year end?
Ginkgo Bioworks Holdings, Inc.'s fiscal year ends on December 31.
How much revenue did Ginkgo Bioworks Holdings, Inc. report?
Ginkgo Bioworks Holdings, Inc. reported $170.2M in revenue for calendar year 2025, according to its SEC filings.